Geode Capital Management
ALXN

Geode Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,145,346
Closed -$760M 4929
2021
Q2
$760M Buy
4,145,346
+175,396
+4% +$32.1M 0.1% 166
2021
Q1
$606M Buy
3,969,950
+125,961
+3% +$19.2M 0.09% 198
2020
Q4
$599M Buy
3,843,989
+55,280
+1% +$8.62M 0.1% 176
2020
Q3
$433M Sell
3,788,709
-2,410
-0.1% -$275K 0.08% 219
2020
Q2
$425M Buy
3,791,119
+520,766
+16% +$58.3M 0.09% 202
2020
Q1
$293M Buy
3,270,353
+71,609
+2% +$6.42M 0.08% 240
2019
Q4
$345M Buy
3,198,744
+65,495
+2% +$7.07M 0.07% 279
2019
Q3
$306M Buy
3,133,249
+156,364
+5% +$15.3M 0.07% 279
2019
Q2
$389M Buy
2,976,885
+98,863
+3% +$12.9M 0.09% 214
2019
Q1
$388M Buy
2,878,022
+196,113
+7% +$26.5M 0.1% 198
2018
Q4
$261M Buy
2,681,909
+187,834
+8% +$18.3M 0.08% 242
2018
Q3
$346M Buy
2,494,075
+56,166
+2% +$7.79M 0.1% 205
2018
Q2
$302M Buy
2,437,909
+66,991
+3% +$8.3M 0.09% 216
2018
Q1
$264M Buy
2,370,918
+114,503
+5% +$12.7M 0.09% 236
2017
Q4
$269M Buy
2,256,415
+62,266
+3% +$7.43M 0.09% 224
2017
Q3
$307M Buy
2,194,149
+32,693
+2% +$4.58M 0.11% 182
2017
Q2
$263M Buy
2,161,456
+46,125
+2% +$5.6M 0.1% 198
2017
Q1
$256M Buy
2,115,331
+176,941
+9% +$21.4M 0.11% 195
2016
Q4
$237M Buy
1,938,390
+90,574
+5% +$11.1M 0.11% 184
2016
Q3
$226M Buy
1,847,816
+53,772
+3% +$6.58M 0.11% 181
2016
Q2
$209M Sell
1,794,044
-25,904
-1% -$3.02M 0.11% 183
2016
Q1
$253K Buy
1,819,948
+33,987
+2% +$4.72K 0.13% 145
2015
Q4
$340M Sell
1,785,961
-2,005
-0.1% -$382K 0.19% 103
2015
Q3
$279M Buy
1,787,966
+41,707
+2% +$6.51M 0.17% 118
2015
Q2
$315M Buy
1,746,259
+167,628
+11% +$30.2M 0.18% 110
2015
Q1
$273M Buy
1,578,631
+92,075
+6% +$15.9M 0.16% 128
2014
Q4
$275M Buy
1,486,556
+69,893
+5% +$12.9M 0.16% 121
2014
Q3
$235M Sell
1,416,663
-44,478
-3% -$7.37M 0.15% 134
2014
Q2
$228M Sell
1,461,141
-47,728
-3% -$7.45M 0.15% 145
2014
Q1
$229M Buy
1,508,869
+77,313
+5% +$11.8M 0.15% 133
2013
Q4
$190M Buy
1,431,556
+45,416
+3% +$6.04M 0.13% 152
2013
Q3
$161M Buy
1,386,140
+51,106
+4% +$5.93M 0.13% 161
2013
Q2
$123M Buy
+1,335,034
New +$123M 0.11% 198